Pharmacodynamics and pharmacokinetics of oral topotecan in patients with advanced solid tumours and impaired renal function-Reference-Cited by-同舟云学术

Pharmacodynamics and pharmacokinetics of oral topotecan in patients with advanced solid tumours and impaired renal function

Published:2015-05-20 Issue:2 Volume:80 Page:253-266
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Devriese Lot A.¹²,Witteveen Petronella Els. O.³,Mergui-Roelvink Marja²,Smith Deborah A.⁴,Lewis Lionel D.⁵,Mendelson David S.⁶,Bang Yung-Jue⁷,Chung Hyun Choel⁸,Dar Mohammed M.⁴,Huitema Alwin D. R.⁹,Beijnen Jos H.⁹¹⁰,Voest Emile E.³,Schellens Jan H. M.¹²¹⁰

Affiliation:

1. Division of Experimental Therapy; The Netherlands Cancer Institute; Amsterdam The Netherlands

2. Department of Clinical Pharmacology; The Netherlands Cancer Institute; Amsterdam The Netherlands

3. Department of Medical Oncology; University Medical Center Utrecht; The Netherlands

4. GlaxoSmithKline; Research Triangle Park USA

5. Department of Medicine, The Geisel School of Medicine at Dartmouth and The Norris Cotton Cancer Center; Dartmouth-Hitchcock Medical Center; Lebanon USA

6. Pinnacle Oncology Hematology; Scottsdale USA

7. Department of Internal Medicine; Seoul National University College of Medicine; Seoul South Korea

8. Yonsei Cancer Center; Severance Hospital; Seoul South Korea

9. Department of Pharmacy & Pharmacology; Slotervaart Hospital; Amsterdam The Netherlands

10. Science Faculty, Department of Pharmaceutical Sciences; Utrecht University; The Netherlands

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.12606/fullpdf

Reference40 articles.

1. Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin;Hsiang;Cancer Res,1988

2. Topoisomerase I inhibitors: camptothecins and beyond;Pommier;Nat Rev Cancer,2006

3. Oral topotecan given once or twice daily for ten days: a phase I pharmacology study in adult patients with solid tumors;Gerrits;Clin Cancer Res,1998

4. Phase I and pharmacologic study of oral topotecan administered twice daily for 21 days to adult patients with solid tumors;Creemers;J Clin Oncol,1997

5. A comparison of clinical pharmacodynamics of different administration schedules of oral topotecan (Hycamtin);Gerrits;Clin Cancer Res,1999

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug–Drug Interactions of Cannabidiol with Standard-of-Care Chemotherapeutics;International Journal of Molecular Sciences;2023-02-02

2. The Novel Dual Topoisomerase Inhibitor P8-D6 Shows Anti-myeloma Activity In Vitro and In Vivo;Molecular Cancer Therapeutics;2021-11-01

3. Medicinal Potential of Heterocyclic Compounds from Diverse Natural Sources for the Management of Cancer;Mini-Reviews in Medicinal Chemistry;2020-07-17

4. Conventional chemotherapy;Onco-Nephrology;2020

5. Therapeutic Opportunities in Neuroblastoma Using Nanotechnology;Journal of Pharmacology and Experimental Therapeutics;2019-01-11